newsfilter
← Latest News
GlobeNewswire·

Charming Medical Limited Announces Receipt of Nasdaq Delisting Determination Notice.

  • Charming Medical Limited (NASDAQ: MCTA) received a delisting determination letter from Nasdaq on October 29, 2026.
  • The delisting follows an SEC trading suspension order issued on November 11, 2025, regarding potential market manipulation via social media recommendations.
  • Nasdaq cited Listing Rule IM-5101-4, which allows delisting when the SEC suspends trading due to third-party misconduct impacting a company's securities.
  • Unless the Company appeals by November 5, 2026, trading will be suspended on November 9, 2026.
  • Nasdaq will file a Form 25-NSE with the SEC to remove the securities from listing & registration.
  • Nasdaq has not determined that the Company engaged in wrongdoing in connection with the trading activity.
  • The delisting does not affect the Company's ongoing business operations or financial condition.
  • The Company's securities may become eligible for over-the-counter (OTC) trading, though no active secondary market is guaranteed.